Titan America S.A.
NYSE:TTAMConstruction Materials
+$0.49 today
- Market cap
- $2.04B
- Beta
- 1.13
- P/E (TTM)
- 18.0
- EPS (TTM)
- $1.00
- Dividend yield
- 1.11%
Volume 0.34M
Average 0.29M
TTAM Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Titan America S.A.NYSE: TTAM
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How TTAM compares with its peers on the latest reported figures
- TTAM's LTM Jun 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for TTAM, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
TTAMTitan America S.A. | LTM Jun 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TTAM) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for TTAM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.15B | 1.36B | 1.59B | 1.63B | 1.66B |
| Cost of Revenue | 956.26M | 1.14B | 1.23B | 1.22B | 1.23B |
| Gross Profit | 196.16M | 221.27M | 363.49M | 416.66M | 434.99M |
| Gross Margin | 17.0% | 16.2% | 22.8% | 25.5% | 26.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 93.83M | 110.56M | 122.25M | 153.58M | 163.49M |
| Operating Expenses | 101.98M | 124.22M | 137.85M | 165.27M | 163.49M |
| Depreciation & Amortization | 81.73M | 87.73M | 91.08M | 99.94M | 108.72M |
| EBITDA | 177.37M | 188.81M | 314.24M | 348.71M | 376.12M |
| EBITDA Margin | 15.4% | 13.8% | 19.7% | 21.3% | 22.6% |
| Operating Income | 94.18M | 97.04M | 225.64M | 251.39M | 271.5M |
| Operating Margin | 8.2% | 7.1% | 14.2% | 15.4% | 16.3% |
| Interest Income | 471K | 436K | 950K | 1.47M | 0 |
| Interest Expense | 21.08M | 21.39M | 20.78M | 25.15M | 22.56M |
| Other Income / Expenses | (19.62M) | (17.35M) | (23.26M) | (27.77M) | (26.66M) |
| Income Before Tax | 74.56M | 79.69M | 202.38M | 223.62M | 244.84M |
| Pre-Tax Margin | 6.5% | 5.8% | 12.7% | 13.7% | 14.7% |
| Income Tax Expense | 15.34M | 16.97M | 47.13M | 57.54M | 59.4M |
| Net Income | 59.22M | 62.72M | 155.24M | 166.07M | 185.44M |
| Net Margin | 5.1% | 4.6% | 9.8% | 10.2% | 11.1% |
| EPS (Basic) | 0.32 | 0.34 | 0.84 | 0.90 | 1.01 |
| EPS (Diluted) | 0.32 | 0.34 | 0.84 | 0.90 | 1.01 |
| Weighted Avg Shares | 184.36M | 184.36M | 184.36M | 184.36M | 183.35M |
| Weighted Avg Shares (Diluted) | 184.36M | 184.36M | 184.36M | 184.36M | 183.46M |
Titan America S.A.
NYSE:TTAM
Intrinsic Alpha fair value
Locked
Current Price
$11.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.